Nonetheless, our current data may offer important clinical information since it provides primary evidence for the differential expression of In1-ghrelin, GOAT and GHSR1b in breast cancer tissues, which may represent novel diagnostic/prognostic markers and therapeutic targets for this pathology. This evidence concerns the gene MBOAT4 and breast cancer.